Showing 1 - 7 results of 7 for search 'Xuewen MA', query time: 0.05s
Refine Results
-
1
-
2
-
3
Training dictionary by granular computing with L∞-norm for patch granule–based image denoising by Hongbing Liu, Gengyi Liu, Xuewen Ma, Daohua Liu
Published 2018-06-01
Article -
4
β-Cyclodextrin–Hyaluronic Acid Polymer Functionalized Magnetic Graphene Oxide Nanocomposites for Targeted Photo-Chemotherapy of Tumor Cells by Wenting Liang, Yu Huang, Dongtao Lu, Xuewen Ma, Tao Gong, Xiaodong Cui, Baofeng Yu, Cheng Yang, Chuan Dong, Shaomin Shuang
Published 2019-01-01
Article -
5
Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy by Michael A. Tortorici, Theresa Yuraszeck, David Cornblath, Vera Bril, Hans‐Peter Hartung, Gen Sobue, Richard A. Lewis, Ingemar S. J. Merkies, John‐Philip Lawo, Michaela Praus, Billie L. Durn, Orell Mielke, Xuewen Ma, Petra Jauslin, Marc Pfister, Ivo N. vanSchaik, the PATH study group
Published 2021-08-01
Article -
6
P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MON... by Leo Rasche, Carolina Schinke, Ajai Chari, Brea C. Lipe, Noa Lavi, Paula Rodríguez-Otero, Deeksha Vishwamitra, Sheri Skerget, Raluca Verona, Xuewen MA, Sheetal Khedkar, Brandi Hilder, Tara Masterson, Michela Campagna, Thomas Renaud, Jaszianne Tolbert, Christoph Heuck, Damiette Smit, Niels W.C.J. van de Donk
Published 2023-08-01
Article -
7
S191: PIVOTAL PHASE 2 MONUMENTAL-1 RESULTS OF TALQUETAMAB (TAL), A GPRC5DXCD3 BISPECIFIC ANTIBODY (BSAB), FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) by Cyrille Touzeau, Carolina Schinke, Monique Minnema, Niels W.C.J. van de Donk, Paula Rodríguez-Otero, Maria-Victoria Mateos, Leo Rasche, Jing Christine Ye, Deeksha Vishwamitra, Xuewen MA, Xiang Qin, Michela Campagna, Tara Masterson, Brandi Hilder, Jaszianne Tolbert, Thomas Renaud, Jenna Goldberg, Christoph Heuck, Ajai Chari
Published 2023-08-01
Article